SRE vs EXC

For growth investors, Sempra (SRE) is the stronger pick with 5.

8% revenue growth year-over-year, versus 5. 3% for Exelon Corporation (EXC). Exelon Corporation (EXC) offers the better valuation at 16. 2x trailing P/E (15. 6x forward), making it the more compelling value choice. Analysts rate Sempra (SRE) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Exelon Corporation (EXC) is the cheapest at 16.

2x versus Sempra at 33. 3x. On forward P/E, Exelon Corporation is actually cheaper at 15. 6x.

Over the past 5 years, Exelon Corporation (EXC) delivered a total return of +61.

8%, compared to +50. 4% for Sempra (SRE). Over 10 years, the gap is even starker: EXC returned +125. 0% versus SRE's +115. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Exelon Corporation (EXC) is the lower-risk stock at -0.

14β versus Sempra's 0. 37β — meaning SRE is approximately -365% more volatile than EXC relative to the S&P 500. On balance sheet safety, Sempra (SRE) carries a lower debt/equity ratio of 86% versus 176% for Exelon Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Sempra (SRE) is pulling ahead at 5.

8% versus 5. 3% for Exelon Corporation (EXC). On earnings-per-share growth, the picture is similar: Exelon Corporation grew EPS 11. 8% year-over-year, compared to -37. 8% for Sempra. Over a 3-year CAGR, EXC leads at 8. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Sempra (SRE) is the more profitable company, earning 13.

4% net margin versus 11. 4% for Exelon Corporation — meaning it keeps 13. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SRE leads at 23. 7% versus 21. 2% for EXC. At the gross margin level — before operating expenses — SRE leads at 29. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Exelon Corporation (EXC) trades at 15.

6x forward P/E versus 17. 9x for Sempra — 2. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SRE: 16. 8% to $107. 00.

All stocks in this comparison pay dividends.

Exelon Corporation (EXC) offers the highest yield at 3. 6%, versus 2. 7% for Sempra (SRE).

For long-horizon retirement investors, Exelon Corporation (EXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

14), 3. 6% yield, +125. 0% 10Y return). Both have compounded well over 10 years (EXC: +125. 0%, SRE: +115. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Utilities sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SRE is a mid-cap quality compounder stock; EXC is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.